Evergreen Capital Management’s Core Laboratories CLB Stock Holding History

Evergreen Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.8M	Buy	+669,508	New	+$9.56M	0.14%	153

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Evergreen Capital Management's CLB Position: Q2 2026 in Review

Evergreen Capital Management opened a new position in Core Laboratories (CLB) in Q2 2026: 669,508 shares worth $7.8M. The stake represents 0.14% of the portfolio and ranks #153 among its holdings.

186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Evergreen Capital Management held 669,508 shares of Core Laboratories worth $7.8M as of Q2 2026.
Core Laboratories was a new Evergreen Capital Management position in Q2 2026.
Core Laboratories made up 0.14% of Evergreen Capital Management's portfolio in Q2 2026, its #153 holding.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.